Biomarkers in Traumatic Lung Injury - A Systematic Review | Synapse
March 24, 2026Open Access
Biomarkers in Traumatic Lung Injury - A Systematic Review
Key Points
This review aims to identify and evaluate biomarkers that assist in the early diagnosis of traumatic lung injury (TLI) and assess its severity.
Conducted a systematic review of existing literature on biomarkers for TLI.
Included studies that focus on CC16, sRAGE, and angiopoietin 2.
Analyzed the prognostic potential of identified biomarkers.
CC16, sRAGE, and angiopoietin 2 are highlighted as the most promising biomarkers.
These biomarkers are suggested as valuable tools for early diagnosis and severity stratification of TLI.
Abstract
Biomarkers show promise for early TLI diagnosis and stratification. CC16, sRAGE, and angiopoietin 2 emerge as the most promising biomarkers for prognosticating the severity of TLI.